A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia

Recruiting

Plain-English translation of NCT07935356 on ClinicalTrials.gov ↗ · Source last updated November 2026 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(9 sites)

United States

University of California San Diego (UC San Diego) Health - Jacobs Medical Center, La Jolla, California

Children's Hospital Los Angeles, Los Angeles, California

University of California Davis (UC Davis) Medical Center, Sacramento, California

University of California San Francisco (UCSF) Medical Center, San Francisco, California

Innovative Hematology - Indiana Hemophilia & Thrombosis Center, Indianapolis, Indiana